关于欧洲专家对"癌症幸存者"和相关术语的看法的e-Delphi研究
Amy Taylor1,2, Andrew Davies3,4,5,
1School of Medicine, Trinity College Dublin, Dublin, Ireland. tayloram@tcd.ie.
Journal of cancer survivorship : research and practice
|January 31, 2026
概括
欧洲专家建议,术语"癌症幸存者"只应适用于没有疾病证据的治疗后个人. 这种共识旨在改善针对不同患者群体量身定制的癌症护理模式.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 对癌症幸存者的定义和分类各不相同.
- 这种模糊性影响了有效的护理模式的发展.
- 需要标准化的术语,以保持一致的患者护理.
研究的目的:
- 为了在癌症幸存者术语上达成欧洲专家共识.
- 建立对有癌症病史的个体的明确分类.
- 为制定一个全面的癌症护理模式提供信息.
主要方法:
- 一项电子Delphi研究,涉及欧洲专家息护理 (SPC) 和瘤学 (ONC) 专家.
- 专家和患者倡导者的有目的抽样.
- 在105个声明上进行了多轮的共识建设,共识定义为≥75%的同意.
主要成果:
- 达成共识的是",癌症幸存者"适用于治疗后没有疾病证据的个人.
- 两种癌症患者群体的分类在专家之间达成了共识.
- 在SPC和ONC组之间的其他陈述上,人们注意到了意见的显著差异.
结论:
- 专家建议重新考虑将"癌症幸存者"适用于活跃癌症患者.
- 对癌症患者的务实分类可以促进量身定制的护理.
- 这种共识为改善癌症幸存者护理提供了基础.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


